Pre-Transplant Cardiac Evaluation in Liver Transplant Recipients

Area of Science:

• Cardiology
• Hepatology
• Transplantation Medicine

Background:

• Liver transplantation (LT) is a vital treatment for end-stage liver disease and liver cancer.
• Cardiovascular comorbidities are increasingly prevalent in liver disease patients.
• Adverse cardiac events are a major cause of death after LT.

Purpose of the Study:

• To review current data on cardiac pathologies in LT candidates.
• To analyze the impact of cardiac conditions on waitlist and post-LT outcomes.
• To discuss advancements in cardiac risk stratification and management for LT recipients.

Main Methods:

• Literature review of recent studies on cardiac issues in LT candidates.
• Analysis of epidemiological data on cardiovascular comorbidities in liver disease.
• Examination of diagnostic tools for cardiac risk assessment.
• Synthesis of clinical management strategies for pre-LT cardiac risk mitigation.

Main Results:

• Specific cardiac pathologies are common in LT candidates.
• Pre-existing cardiac conditions significantly influence waitlist mortality and post-LT morbidity.
• Novel screening diagnostics offer improved cardiac risk stratification.
• Proactive clinical management can mitigate cardiac risks.

Conclusions:

• Comprehensive cardiac evaluation is essential for LT candidate selection.
• Addressing cardiovascular comorbidities improves LT outcomes.
• Ongoing research in cardiac risk assessment and management is vital for advancing LT practices.